New Acting Commissioner Von Eschenbach Brings Capitol Hill Clout – Gottlieb
This article was originally published in The Tan Sheet
Executive Summary
FDA Acting Commissioner Andrew von Eschenbach's "clout on the Hill" could temper the perceived weakness usually associated with acting status, according to Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb, MD